{"id":"f-13418-158-eye-drops","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As an eye drop formulation in Phase 3 development by Johnson & Johnson Consumer Inc., this drug likely works through ocular surface lubrication and/or anti-inflammatory mechanisms to alleviate symptoms of dry eye disease. The specific active pharmaceutical ingredient and exact mechanism are not publicly disclosed in available sources, but the therapeutic class suggests symptom relief and corneal protection.","oneSentence":"F#13418-158 is an ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:12:11.142Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye disease (presumed, based on formulation type)"}]},"trialDetails":[{"nctId":"NCT03198000","phase":"PHASE3","title":"A Study to Evaluate the Efficacy of Investigational OTC Eye Drops","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer Inc. (J&JCI)","startDate":"2017-06-28","conditions":"Ophthalmic Solutions","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"F#13418-158 Eye Drops","genericName":"F#13418-158 Eye Drops","companyName":"Johnson & Johnson Consumer Inc. (J&JCI)","companyId":"johnson-johnson-consumer-inc-j-jci","modality":"Small molecule","firstApprovalDate":"","aiSummary":"F#13418-158 is an ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface. Used for Dry eye disease (presumed, based on formulation type).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}